Use of mammographic screening by HIV-infected women in the Women's Interagency HIV Study (WIHS)

Preventive Medicine
Susan Preston-MartinAlexandra M Levine

Abstract

Although HIV-positive women may be less likely than women in general to receive mammography due to socioeconomic disadvantage, HIV diagnosis may increase opportunities for medical interactions which encourage mammography. HIV-positive (2,059) and HIV-negative (569) Women's Interagency HIV Study (WIHS) participants reported ever/never history of mammography at baseline (in 1994, 1995) and, at each 6-month follow-up visit, if they had been screened since their last visit. National Health Interview Survey (NHIS) data for 1994 were used to compare WIHS participants to U.S. women. Factors independently related to mammography were determined using logistic regression for baseline data and proportional hazards for follow-up data. Results were adjusted for age. Among women > or =40, fewer WIHS women, regardless of HIV status, reported screening than U.S. women (67% HIV-positive, 62% HIV-negative, 79% NHIS; P < 0.0001). First-time screening while on study was associated with being HIV-positive [rate ratio (95% confidence interval) = 1.6 (1.1, 2.3)]. Factors independently associated with screening were related to health care access and usage. WIHS women, a disadvantaged population, reported less mammography than the general population. H...Continue Reading

Associated Clinical Trials

References

Oct 1, 1992·American Journal of Public Health·D DegnanJ Gonzalez
Jul 1, 1996·American Journal of Public Health·J G ZapkaE Sachsse
Aug 1, 1996·Annals of Internal Medicine·R B BurnsM A Moskowitz
Aug 1, 1996·Journal of the American Geriatrics Society·R B BurnsM A Moskowitz
Apr 4, 1998·Health Care for Women International·N P PeragalloM L Alba
May 6, 1998·American Journal of Preventive Medicine·P G McGovernJ S Slater
Sep 13, 2000·American Journal of Public Health·N DuanS Carson
Sep 30, 2000·Journal of Health Communication·K P DeroseJ Hawes-Dawson

❮ Previous
Next ❯

Citations

Apr 1, 2008·AIDS Patient Care and STDs·John R KoetheKrystn R Wagner
Jul 11, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John F DeekenBruce J Dezube
Sep 23, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Meredith S ShielsCharles Poole
Dec 24, 2010·PloS One·Nancy A HessolJames J Goedert
Jun 8, 2013·AIDS Care·Florence MomplaisirJudith A Long
May 12, 2016·Journal of Women's Health·Zoe M WeinsteinAmy S Baranoski
Apr 7, 2015·Seminars in Oncology·Andrew E Grulich, Claire M Vajdic
Jul 27, 2006·British Journal of Cancer·J J GoedertUNKNOWN HIV/AIDS Cancer Match Study
Apr 11, 2009·Current HIV/AIDS Reports·Adrienne A Phillips, Jessica E Justman
Oct 5, 2019·JMIR Research Protocols·Andrea L WirtzUNKNOWN American Cohort To Study HIV Acquisition Among Transgender Women (LITE)
Mar 30, 2011·Journal of the International AIDS Society·Nicolas DaubyNathan Clumeck
May 20, 2020·Journal of Community Health·Amanda Blair SpencePrincy Kumar
Oct 3, 2017·HIV Medicine·L TronUNKNOWN Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 Study Group
Jan 26, 2021·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Sally B CoburnUNKNOWN North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiology Databases to E

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.